Discovery of a potent dual EGFR/HER-2 inhibitor L-2 (selatinib) for the treatment of cancer

Autor:	Zhang, Long, Fan, Chuanwen, Guo, Zongru, Li, Ying, Zhao, Shuyong, Yang, Shaobo, Yang, Yingying, Zhu, Jianrong, Lin, Dong
Zdroj:	In European Journal of Medicinal Chemistry November 2013 69:833-841
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect